← Doximity overview

Doximity vs C3 Ai: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Doximity Inc (DOCS)

Q3 2026
▲3▼1

Doximity's AI Bet Pays Off With Blowout Quarter, But Margins Shrink

  • Blowout Q1 earnings and raised guidance Doximity reported fiscal Q1 revenue of $156.6 million, beating the $151.7 million consensus, and raised its full-year targets. The stock soared 66% in premarket trading. This directly boosts the share price because it shows the business is growing faster than expected and management is confident enough to raise guidance.

    This is the single biggest new event of the period and the main reason DOCS moved sharply higher.

  • AI investments show strong returns CEO Jeff Tangney said AI prompt volume grew over 25% quarter-on-quarter and AI Scribe users jumped tenfold year-over-year. An independent study found Doximity's AI assistant had the lowest clinical error rates. This supports the stock because it shows the company's heavy AI spending is producing real user growth and a competitive edge.

    It explains why investors are optimistic about the AI strategy despite near-term costs.

  • AI spending squeezes profit margins Adjusted gross margin fell 300 basis points to 88% due to higher AI compute costs, and management expects adjusted EBITDA margin to drop to 47% for the year. This pressures the stock because it means profits are shrinking even as revenue grows, and the company expects the spending to continue.

    It is the main counterweight to the positive AI news and a key reason the stock doesn't just go straight up.

  • AI Search and clinical AI adoption accelerate Doximity's AI Search business onboarded its first cohort across more than two dozen programs, and quarterly active workflow prescribers rose over 30% year-over-year, with 165 signed health-system AI clients. This lifts the stock because it shows new AI products are gaining traction and opening a multibillion-dollar market beyond the core physician network.

    It provides concrete evidence that the AI pivot is translating into new customers and revenue streams.

July 2026
▲3▼1

Doximity's AI Bet Pays Off With Blowout Quarter, But Margins Shrink

  • Blowout Q1 earnings and raised guidance Doximity reported fiscal Q1 revenue of $156.6 million, beating the $151.7 million consensus, and raised its full-year targets. The stock soared 66% in premarket trading. This directly boosts the share price because it shows the business is growing faster than expected and management is confident enough to raise guidance.

    This is the single biggest new event of the period and the main reason DOCS moved sharply higher.

  • AI investments show strong returns CEO Jeff Tangney said AI prompt volume grew over 25% quarter-on-quarter and AI Scribe users jumped tenfold year-over-year. An independent study found Doximity's AI assistant had the lowest clinical error rates. This supports the stock because it shows the company's heavy AI spending is producing real user growth and a competitive edge.

    It explains why investors are optimistic about the AI strategy despite near-term costs.

  • AI spending squeezes profit margins Adjusted gross margin fell 300 basis points to 88% due to higher AI compute costs, and management expects adjusted EBITDA margin to drop to 47% for the year. This pressures the stock because it means profits are shrinking even as revenue grows, and the company expects the spending to continue.

    It is the main counterweight to the positive AI news and a key reason the stock doesn't just go straight up.

  • AI Search and clinical AI adoption accelerate Doximity's AI Search business onboarded its first cohort across more than two dozen programs, and quarterly active workflow prescribers rose over 30% year-over-year, with 165 signed health-system AI clients. This lifts the stock because it shows new AI products are gaining traction and opening a multibillion-dollar market beyond the core physician network.

    It provides concrete evidence that the AI pivot is translating into new customers and revenue streams.

Latest
▲3▼1

Doximity's AI Bet Pays Off With Blowout Quarter, But Margins Shrink

  • Blowout Q1 earnings and raised guidance Doximity reported fiscal Q1 revenue of $156.6 million, beating the $151.7 million consensus, and raised its full-year targets. The stock soared 66% in premarket trading. This directly boosts the share price because it shows the business is growing faster than expected and management is confident enough to raise guidance.

    This is the single biggest new event of the period and the main reason DOCS moved sharply higher.

  • AI investments show strong returns CEO Jeff Tangney said AI prompt volume grew over 25% quarter-on-quarter and AI Scribe users jumped tenfold year-over-year. An independent study found Doximity's AI assistant had the lowest clinical error rates. This supports the stock because it shows the company's heavy AI spending is producing real user growth and a competitive edge.

    It explains why investors are optimistic about the AI strategy despite near-term costs.

  • AI spending squeezes profit margins Adjusted gross margin fell 300 basis points to 88% due to higher AI compute costs, and management expects adjusted EBITDA margin to drop to 47% for the year. This pressures the stock because it means profits are shrinking even as revenue grows, and the company expects the spending to continue.

    It is the main counterweight to the positive AI news and a key reason the stock doesn't just go straight up.

  • AI Search and clinical AI adoption accelerate Doximity's AI Search business onboarded its first cohort across more than two dozen programs, and quarterly active workflow prescribers rose over 30% year-over-year, with 165 signed health-system AI clients. This lifts the stock because it shows new AI products are gaining traction and opening a multibillion-dollar market beyond the core physician network.

    It provides concrete evidence that the AI pivot is translating into new customers and revenue streams.

C3 Ai Inc (AI)

Q3 2026
▼3▲1

C3.ai's Turnaround Faces Deep Skepticism as Revenue Plunges

  • Revenue collapse and margin erosion Revenue fell 36% in FY2026 and gross margin dropped from 62% to 22%, with free cash flow at negative $192 million. FY2027 guidance implies further shrinkage, raising doubts about the business's stability.

    This point explains the core financial deterioration that pressured the stock.

  • Early turnaround signs emerge Q1 FY2027 bookings jumped 73% with new deals from Ford, J&J, and federal agencies. Free cash flow turned positive at $2.1 million, and a 40% headcount cut saves about $135 million annually.

    This point highlights the positive operational changes that could support a recovery.

  • CEO health absence and sales disruption CEO Thomas Siebel's health-related absence caused sales to 'fall off a cliff,' though he returned in June. The disruption added uncertainty during an already challenging period.

    This point identifies a key leadership risk that hurt sales and investor confidence.

  • Intense competition and high short interest Competitors like Palantir and Snowflake are growing far faster, while short interest at 42% signals deep skepticism. Fed rate uncertainty adds pressure, making the turnaround harder.

    This point captures external competitive and market pressures that weigh on the stock.

September 2026
▼2▲1

C3.ai's turnaround: bookings up, revenue still falling

  • Bookings jump 73% and cash turns positive C3.ai's fiscal Q1 2027 bookings rose 73% from the prior quarter, with 22 new deals including Ford, Johnson & Johnson and federal agencies. Free cash flow turned positive at $2.1 million, and a 40% headcount cut is saving about $135 million a year. This supports the stock by showing the turnaround is gaining traction.

    This is the core new fundamental event of the period and the main reason the stock has a positive case.

  • Revenue still shrinking and guidance disappoints Revenue of $52.4 million fell about 25% from a year earlier, and next-quarter guidance of $53 million missed analyst estimates by 8%. Management also said gross margin will slip back to the mid-40s next quarter. Falling sales and soft guidance weigh on the stock because they show the business is still shrinking.

    This is the main counterweight to the turnaround story and explains why the stock did not rally more.

  • Competitors like Palantir and Snowflake are growing much faster Palantir's commercial revenue more than doubled to $945 million, and Snowflake's product revenue rose 37% to $1.49 billion, while C3.ai's revenue fell. This contrast makes C3.ai look like a laggard in the AI software race, pressuring its stock as investors favor faster-growing peers.

    It shows the competitive backdrop that makes C3.ai's shrinking revenue a bigger problem for investors.

  • Heavy short selling shows deep investor skepticism Short interest stood at 42% of the shares available to trade, meaning many investors are betting the stock will fall. That can amplify moves in either direction, but it reflects real doubt about whether C3.ai can restore growth. It is a structural overhang on the stock.

    It explains the market's persistent skepticism and why positive news has not lifted the stock more.

Latest
▼2▲1

C3.ai's turnaround: bookings up, revenue still falling

  • Bookings jump 73% and cash turns positive C3.ai's fiscal Q1 2027 bookings rose 73% from the prior quarter, with 22 new deals including Ford, Johnson & Johnson and federal agencies. Free cash flow turned positive at $2.1 million, and a 40% headcount cut is saving about $135 million a year. This supports the stock by showing the turnaround is gaining traction.

    This is the core new fundamental event of the period and the main reason the stock has a positive case.

  • Revenue still shrinking and guidance disappoints Revenue of $52.4 million fell about 25% from a year earlier, and next-quarter guidance of $53 million missed analyst estimates by 8%. Management also said gross margin will slip back to the mid-40s next quarter. Falling sales and soft guidance weigh on the stock because they show the business is still shrinking.

    This is the main counterweight to the turnaround story and explains why the stock did not rally more.

  • Competitors like Palantir and Snowflake are growing much faster Palantir's commercial revenue more than doubled to $945 million, and Snowflake's product revenue rose 37% to $1.49 billion, while C3.ai's revenue fell. This contrast makes C3.ai look like a laggard in the AI software race, pressuring its stock as investors favor faster-growing peers.

    It shows the competitive backdrop that makes C3.ai's shrinking revenue a bigger problem for investors.

  • Heavy short selling shows deep investor skepticism Short interest stood at 42% of the shares available to trade, meaning many investors are betting the stock will fall. That can amplify moves in either direction, but it reflects real doubt about whether C3.ai can restore growth. It is a structural overhang on the stock.

    It explains the market's persistent skepticism and why positive news has not lifted the stock more.

July 2026
▼3▲1

C3.ai's Revenue Collapse and Weak Guidance Drive Bearish Outlook

  • Revenue Collapse and Weak Guidance C3.ai's fiscal 2026 revenue fell 36% to $250 million, with Q4 down 52%. Gross margin plunged from 62% to 22%, and free cash flow turned negative $192 million. Management's FY2027 guidance implies further shrinkage, signaling deep operational troubles.

    This is the core fundamental driver: collapsing sales and profitability directly pressure the stock price.

  • CEO Health Leave and Return CEO Thomas Siebel resigned due to health issues, then returned in June. During his absence, sales 'fell off the cliff' across five quarters. His return may stabilize operations, but the revenue decline continued, leaving uncertainty about leadership and execution.

    Leadership instability during a critical period exacerbates the revenue decline and investor confidence.

  • Securities Class Action Dismissed C3.ai secured a full dismissal of a securities class action, removing legal uncertainty and potential financial penalties. This reduces risk for the company and may improve investor sentiment, though it doesn't address the core revenue challenges.

    This legal win removes a negative overhang, providing a rare positive catalyst amid operational struggles.

  • Fed Signals End of Easing Cycle The Federal Reserve's dot plot removed expectations for a 2026 rate cut and introduced the possibility of a hike. Higher rates reduce the present value of future cash flows, pressuring high-growth software stocks like C3.ai, which already face revenue declines.

    Monetary policy tightening adds external pressure on valuation, compounding company-specific issues.

▼3▲1

C3.ai's Revenue Collapse and Weak Guidance Drive Bearish Outlook

  • Revenue Collapse and Weak Guidance C3.ai's fiscal 2026 revenue fell 36% to $250 million, with Q4 down 52%. Gross margin plunged from 62% to 22%, and free cash flow turned negative $192 million. Management's FY2027 guidance implies further shrinkage, signaling deep operational troubles.

    This is the core fundamental driver: collapsing sales and profitability directly pressure the stock price.

  • CEO Health Leave and Return CEO Thomas Siebel resigned due to health issues, then returned in June. During his absence, sales 'fell off the cliff' across five quarters. His return may stabilize operations, but the revenue decline continued, leaving uncertainty about leadership and execution.

    Leadership instability during a critical period exacerbates the revenue decline and investor confidence.

  • Securities Class Action Dismissed C3.ai secured a full dismissal of a securities class action, removing legal uncertainty and potential financial penalties. This reduces risk for the company and may improve investor sentiment, though it doesn't address the core revenue challenges.

    This legal win removes a negative overhang, providing a rare positive catalyst amid operational struggles.

  • Fed Signals End of Easing Cycle The Federal Reserve's dot plot removed expectations for a 2026 rate cut and introduced the possibility of a hike. Higher rates reduce the present value of future cash flows, pressuring high-growth software stocks like C3.ai, which already face revenue declines.

    Monetary policy tightening adds external pressure on valuation, compounding company-specific issues.

© 2026 MarketDXWhy